Efficacy and Safety Study of F373280 for Maintenance of Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation and Chronic Heart Failure. International, Multicentric, Randomised, Double-blind, Placebo Controlled Study.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 30 May 2017
At a glance
- Drugs F 373280 (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 27 May 2017 Trial has been completed in Czech Republic (end date: 3 Apr 2017).
- 25 May 2017 Trial has been completed in Spain.
- 08 Nov 2016 Status changed from discontinued to active, no longer recruiting.